186 related articles for article (PubMed ID: 33367931)
21. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma.
Ni H; Ji D; Li J; Zhao Z; Zuo J
Int J Biol Macromol; 2021 Apr; 176():145-156. PubMed ID: 33571591
[TBL] [Abstract][Full Text] [Related]
22. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
23. LncRNA CASC7 inhibits the progression of glioma via regulating Wnt/β-catenin signaling pathway.
Gong X; Liao X; Huang M
Pathol Res Pract; 2019 Mar; 215(3):564-570. PubMed ID: 30661904
[TBL] [Abstract][Full Text] [Related]
24. RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway.
Sun J; Ma Q; Li B; Wang C; Mo L; Zhang X; Tang F; Wang Q; Yan X; Yao X; Wu Q; Shu C; Xiong J; Fan W; Wang J
Cell Death Dis; 2020 Oct; 11(10):890. PubMed ID: 33087705
[TBL] [Abstract][Full Text] [Related]
25. SOX15 exerts antitumor function in glioma by inhibiting cell proliferation and invasion via downregulation of Wnt/β-catenin signaling.
Zhang D; Guo S; Wang H; Hu Y
Life Sci; 2020 Aug; 255():117792. PubMed ID: 32416168
[TBL] [Abstract][Full Text] [Related]
26. SMARCC2 combined with c‑Myc inhibits the migration and invasion of glioma cells via modulation of the Wnt/β‑catenin signaling pathway.
Li C; Fei C; Li J; Wu H; Chen L; Roshani R; Li H; Shi L; Song C; Gu J; Lu Y; Zhou Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34080022
[TBL] [Abstract][Full Text] [Related]
27. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
Yu X; Wang M; Wu J; Han Q; Zhang X
J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
[TBL] [Abstract][Full Text] [Related]
28. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway.
Wang M; Li C; Shi W
Biofactors; 2021 Jul; 47(4):600-611. PubMed ID: 33759248
[TBL] [Abstract][Full Text] [Related]
29. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
30. Tissue-specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA-125a-5p in lung cancer.
Gao Y; Zhang G; Liu J; Li H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760213
[TBL] [Abstract][Full Text] [Related]
31. MiRNA-92a promotes cell proliferation and invasion through binding to KLF4 in glioma.
Liu PJ; Ye YX; Wang YX; Du JX; Pan YH; Fang XB
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6612-6620. PubMed ID: 31378903
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA H19 regulates the development of gliomas through the Wnt/β-catenin signaling pathway.
Guan N; Wang R; Guo WS; Lai YJ; Zhang YD; Cheng YY
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4243-4253. PubMed ID: 31173296
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-222 promotes tumorigenesis via targeting DKK2 and activating the Wnt/β-catenin signaling pathway.
Li Q; Shen K; Zhao Y; He X; Ma C; Wang L; Wang B; Liu J; Ma J
FEBS Lett; 2013 Jun; 587(12):1742-8. PubMed ID: 23587485
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
Ma S; Fu T; Zhao S; Gao M
Eur J Pharmacol; 2019 Jun; 852():42-50. PubMed ID: 30851271
[TBL] [Abstract][Full Text] [Related]
35. MiR-182 promotes prostate cancer progression through activating Wnt/β-catenin signal pathway.
Wang D; Lu G; Shao Y; Xu D
Biomed Pharmacother; 2018 Mar; 99():334-339. PubMed ID: 29353209
[TBL] [Abstract][Full Text] [Related]
36. AMOTL2‑knockdown promotes the proliferation, migration and invasion of glioma by regulating β‑catenin nuclear localization.
Chen X; Lu Y; Guo G; Zhang Y; Sun Y; Guo L; Li R; Nan Y; Yang X; Dong J; Jin X; Huang Q
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036399
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA‑21 promotes migration and invasion of glioma cells via activation of Sox2 and β‑catenin signaling.
Luo G; Luo W; Sun X; Lin J; Wang M; Zhang Y; Luo W; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):187-193. PubMed ID: 27909726
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-675 promotes glioma cell proliferation and motility by negatively regulating retinoblastoma 1.
Zheng Y; Lu X; Xu L; Chen Z; Li Q; Yuan J
Hum Pathol; 2017 Nov; 69():63-71. PubMed ID: 28970140
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
Sun WM; Tao W; Li JC; Zhu DM; Miao Y
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
[TBL] [Abstract][Full Text] [Related]
40. The lncRNA HOXA11-AS promotes glioma cell growth and metastasis by targeting miR-130a-5p/HMGB2.
Xu CH; Xiao LM; Liu Y; Chen LK; Zheng SY; Zeng EM; Li DH
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):241-252. PubMed ID: 30657566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]